4//SEC Filing
Shah Gaurav 4
Accession 0001140361-25-004296
CIK 0001281895other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:01 PM ET
Size
8.6 KB
Accession
0001140361-25-004296
Insider Transaction Report
Form 4
Shah Gaurav
DirectorCEO
Transactions
- Award
Common Stock
2025-02-11+81,655→ 788,983 total - Award
Stock Option (Right to Buy)
2025-02-11+243,345→ 243,345 totalExercise: $9.88Exp: 2035-02-11→ Common Stock (243,345 underlying)
Holdings
- 198,341(indirect: By Trust)
Common Stock
- 207,897(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]This option represents a right to purchase a total of 243,345 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001725922
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:01 PM ET
- Size
- 8.6 KB